Market Place
Sourcing Support
Vittoria Bio Doses 1st Patient in VIPER-101 Phase 1 Trial
19 Dec 2024 //
GLOBENEWSWIRE
Vittoria Bio Presents Preclinical CAR-T Data at ASH 2024
09 Dec 2024 //
GLOBENEWSWIRE
Vittoria Bio Announces Presentations at 66th ASH Annual Meeting
25 Nov 2024 //
GLOBENEWSWIRE
Vittoria Bio Completes $25 Million Financing for Cell Therapies
12 Nov 2024 //
GLOBENEWSWIRE
Vittoria Biotherapeutics Publishes In Science Immunology
22 Jul 2024 //
GLOBENEWSWIRE
Vittoria Biotherapeutics Announces Keith Westby as Chief Operating Officer
16 Apr 2024 //
GLOBENEWSWIRE
Vittoria Announces Appointment of Life Sciences Veteran Rosemary Mazanet as CMO
27 Feb 2024 //
GLOBENEWSWIRE
Vittoria Bio Announces FDA Clearance of IND Application for VIPER-101
07 Dec 2023 //
GLOBENEWSWIRE
Vittoria Announces Presentation of Data Supporting the Company`s Platform
29 Nov 2023 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.